Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PuraStat for hemostasis in exudative hemorrhage after thyroidectomy
jRCTs042250160Active, not recruiting
- Sponsor
- 3-D Matrix
- Start
- Feb 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of PuraStat in thyroid disease and Postoperative Thyroidectomy Hemorrhage (POH), sponsored by 3-D Matrix. Primary endpoint: Proportion requiring additional hemostatic intervention. Started Feb 2026; status: active, not recruiting.
02
Drugs
PuraStat
03
Conditions
thyroid diseasePostoperative Thyroidectomy Hemorrhage (POH)
Beyond the preview
Go deeper on jRCTs042250160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs042250160.